Incorrect administration can lead to complications
UnitedHealthcare covers certain GLP-1 receptor agonists, but approval depends on specific plan design, clinical criteria, and whether medications are prescribed for diabetes or weight management
It is also used as first line therapy when metformin is not tolerated, in subjects with renal insufficiency and in combination with thiazolidinediones, sodium glucose transport protein 2 (SGLT2) inhibitors, and insulin
Results from these studies, expected in the coming years, will provide critical evidence regarding the potential neuroprotective effects of GLP-1 therapy
The hormone is secreted in response to nutrient intake, particularly carbohydrates and fats, and exerts multiple beneficial effects on metabolism